相关实验视频

Updated: Jul 8, 2025

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

一个双样本的门德尔随机化分析:化学因子和泛癌瘤之间的因果关系

Kai Cui^1,2, Na Song^1,2, Yanwu Fan¹

¹Department of Pathology, Xinxiang Medical University, Xinxiang, China.

Frontiers in genetics

|December 11, 2023

概括

化学基因可能在癌症发展中发挥作用,其中几个被确定为潜在的风险因素. 这项研究使用了门德尔的随机化来探索这些关联,为癌症预防和治疗提供了新的目标.

科学领域:

在瘤学瘤学.
遗传学遗传学是一种遗传学.
免疫学免疫学免疫学

背景情况:

癌症是全球死亡的主要原因,需要识别新的风险和保护因素.
由于复杂的生物机制,化学因子和癌症之间的确切因果关系尚不清楚.

研究的目的:

调查血清化学水平与患各种癌症的风险之间的潜在因果关系.
为了识别可能作为癌症生物标记物或治疗点的特定化学基因.

主要方法:

使用来自公共数据库的全基因组关联研究 (GWAS) 数据进行了双向门德尔随机化 (MR) 分析.
反变量加权 (IVW) 方法是主要的分析方法,在多个假设测试中应用了邦费罗尼校正.
为了确保发现的稳定性,进行了敏感性分析,包括留出一个方法,评估异质性和性.

主要成果:

包括CCL1,CCL2,CCL8,CCL14,CCL22,CCL23,CCL27和CXCL9在内的几种化学激素被确定为泛癌的潜在风险因素.
对于某些化学因子与特定癌症类型 (例如,肺癌和甲状腺癌的CCL20,结肠癌的CXCL14) 发现了特定的关联.
观察到CCL1和CCL18与乳腺癌之间存在逆因果关系,这表明它们具有保护作用.

结论:

化基因被认为是癌症发病的潜在上游因素.
这些发现表明,化基因可能是未来癌症预防和治疗策略的有价值目标.
血清化莫金度的变化可能作为癌前病变的指标.

关键词:

在GWAS中,GWAS就是GWAS.门德尔的随机化有因果关系的因果关系.化学物质化学物质是化学物质.泛癌瘤 (Pan-carcinoma) 是一种全癌症.

更多相关视频

Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model

Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model

Published on: April 13, 2015

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

相关概念视频

Mutagenicity and Carcinogenicity

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...

Comparing the Survival Analysis of Two or More Groups

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Chemotaxis and Direction of Cell Migration

Chemotaxis and Direction of Cell Migration

Cells can detect chemical cues in their environment and reorganize the cytoskeleton to migrate toward them or away from them. This directional migration, called chemotaxis, is essential during embryogenesis and development, immune response, tissue repair and regeneration, and reproduction. These chemical cues can either attract or repel the cell's movement. For example, axon development is determined by a combination of chemoattractants and chemorepellents that direct the growing axon...